» Articles » PMID: 20439591

Serial Measurements of Lung Function in a Cohort of Young Children with Bronchopulmonary Dysplasia

Overview
Journal Pediatrics
Specialty Pediatrics
Date 2010 May 5
PMID 20439591
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: We aimed to prospectively and longitudinally measure lung function in a cohort of children with bronchopulmonary dysplasia (BPD) during their first 3 years of life.

Methods: Forty-four children with BPD with a mean (+ or - SD) gestational age of 25.6 (+ or - 1.7) weeks and birth weight of 0.767 (+ or - 0.2) kg underwent serial measurements of lung function (maximum flow at functional residual capacity [V(max)FRC] and functional residual capacity [FRC]) at 6, 12, and 24 months after initial discharge from the neonatal care unit.

Results: Compared with normative data, children with BPD had low partial expiratory airflow, measured by V(max)FRC, with mean z score (+ or - SD) of -1.92 (+ or - 1.04), -1.79 (+ or - 1.5), and -1.67 (+ or - 1.5) at 6, 12, and 24 months, respectively. Over time there was no significant improvement in z scores (P = .66), and 45% of the patients had a z score value of less than -2 (2 SDs below the mean) at the end of the study. FRC measurements steadily and significantly increased over time. Partial expiratory flow showed no correlation with gestational age, birth weight, or length of mechanical ventilation. Mean FRC was significantly higher in children who were using bronchodilators and inhaled steroids but showed no correlation with clinical symptoms. Bronchodilator response was initially present in 30% of the patients and declined to 20% at the end of the study.

Conclusions: During the first 3 years of life, children with mostly moderate-to-severe BPD continue to show significant abnormalities with airflow limitation according to lung-function testing.

Citing Articles

Pulmonary function tests in the neonatal intensive care unit and beyond: a clinical review.

Go M, MacDonald K, Durand M, McEvoy C J Perinatol. 2025; .

PMID: 40021840 DOI: 10.1038/s41372-025-02243-y.


Fingolimod, a sphingosine-1-phosphate receptor modulator, prevents neonatal bronchopulmonary dysplasia and subsequent airway remodeling in a murine model.

Sudhadevi T, Annadi A, Basa P, Jafri A, Natarajan V, Harijith A J Appl Physiol (1985). 2024; 137(5):1231-1242.

PMID: 39262336 PMC: 11563639. DOI: 10.1152/japplphysiol.00311.2024.


Oscillometry and spirometry are not interchangeable when assessing the bronchodilator response in children and young adults born preterm.

Smith E, Bradshaw T, Urs R, Evans D, Hemy N, Hall G Pediatr Pulmonol. 2023; 58(11):3122-3132.

PMID: 37539845 PMC: 10947568. DOI: 10.1002/ppul.26632.


The Role of Lung Function in Determining Which Children Develop Asthma.

McEvoy C, Le Souef P, Martinez F J Allergy Clin Immunol Pract. 2023; 11(3):677-683.

PMID: 36706985 PMC: 10329781. DOI: 10.1016/j.jaip.2023.01.014.


Lifelong Lung Sequelae of Prematurity.

Di Filippo P, Dodi G, Ciarelli F, Di Pillo S, Chiarelli F, Attanasi M Int J Environ Res Public Health. 2022; 19(9).

PMID: 35564667 PMC: 9104309. DOI: 10.3390/ijerph19095273.